Pharmaceutical and Healthcare Labelling
In the wide variety of pharmaceutical labelling applications, labels may be required to have special properties such as:
Labelling small-diameter substrates
On small-diameter substrates, such as test tubes, syringes and vials, labelling requires special attention, especially when the diameter is below 15 mm.
Performance-wise, labelling glass test tubes differs significantly from labelling cyclic olefin copolymer (COC), polyethylene (PE) or polypropylene (PP) test tubes. Overlapped labelling helps assure success, together with an appropriate combination of face material and adhesive.
The importance of traceability
Pharmaceutical products need to be traceable, and pharmaceutical packages usually have batch numbers and expiry dates printed on the label. Accordingly, the printability of the face material, often by thermal transfer, is important.
- Opaque label materials
- Direct Thermal Specials
- Safety First. Pharmaceutical Labelling by UPM Raflatac
- RP 31 Purus – The New Adhesive for Pharmaceuticals
- RP 31 Purus – Det nye klæbestof til lægemidler (Danish)
Safety requirements and certificates
Labelling pharmaceutical products requires specialist face materials and adhesives that meet the requirements of the industry.
Self-adhesive laminates manufactured by UPM Raflatac are safe products in accordance with the material description given by EC Directive 2001/95/EC, Article 2(b).
Material safety data sheets as referred to in Directive 1999/45/EC, Article 14 and Directive 2001/58/EC are not applicable to self-adhesive materials.
The presence of heavy metals is a concern in many applications, including pharmaceutical. UPM Raflatac's products comply with legislation regarding the presence of heavy metals.
* Health and safety
Statement regarding the health and safety of UPM Raflatac's products